This symposium and content was sponsored by the medical department of Merck KGaA.
Timestamps:
- 00:00–09:55 – Opening Remarks (Ravindran Kanesvaran)
- 10:08–31:23 – Right Treatment for the Right Patient: Individualising First-line Therapy in la/mUC (Enrique Grande)
- 31:27–53:40 – Improving Quality of Survival with First-line Maintenance Therapy in la/mUC (Syed Hussain)
- 53:43–1:10:16 – Optimising Outcomes in la/mUC: What Can We Learn from Real-world Evidence? (Ben Tran)
- 1:10:18–1:23:16 – Q&A and Discussion (Panel)
- 1:23:17–1:26:30 – Closing remarks (Ravindran Kanesvaran)
In this symposium chaired by Ravindran Kanesvaran, renowned experts Enrique Grande, Syed Hussain, and Ben Tran discuss the evolving therapeutic landscape in locally advanced/metastatic urothelial carcinoma (la/mUC), and how we can use shared decision making with patients to inform treatment choices.
In this video, the faculty explain the importance of an individualised treatment journey for each patient that aligns with their unique situation, existing co-morbidities, and treatment goals. The presentations include data from pivotal trials, insights from real-world studies, and interesting case studies from the faculty.
The goal is to provide you with practical guidance to enhance your clinical decision-making and improve outcomes for your patients.
Faculty
Ravindran Kanesvaran1
Enrique Grande2
Syed Hussain3
Ben Tran4
1. National Cancer Centre Singapore, Singapore
2. MD Anderson Cancer Center, Madrid, Spain
3. University of Sheffield, UK
4. Peter MacCallum Cancer Centre, Australia
GL-AVE-00702 | January 2025
